NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is offering the Research Specialist Award (R50) under solicitation PAR-28-063 to support exceptional clinician scientists within NCI-funded clinical trials networks. This award provides salary support and autonomy to ensure career continuity for individuals who lead the development of national clinical trials, implement these trials within their institutions, and provide national service through scientific review and monitoring committees. The award is specifically designed for those who do not serve as principal investigators of research project grants. The total project period may not exceed five years, with funded effort required to be between 2.4 and 4.8 person-months per year, capped at a total of 6 person-months across all NCI grants. Additional funding is available for travel to research meetings and conferences, not to exceed 2,500 dollars annually. Applications are evaluated based on the personal accomplishments of the Research Specialist, their contributions to NCI-sponsored networks, the scope of funded trials at their institution, and the level of institutional commitment. Required deliverables include participation in an annual NCI virtual meeting and adherence to annual training in human subjects protection and regulatory compliance. Applicants must maintain active registrations in the System for Award Management (SAM), possess a Unique Entity Identifier (UEI), and have active eRA Commons accounts. The award is governed by 2 CFR Part 200 and 42 CFR Part 52, and recipients must implement cybersecurity incident reporting procedures that notify HHS agencies within 48 hours of discovery.